AABHA SHAKYA
Allopathic & Osteopathic Physicians|Family Medicine JACKSON, MS NPI 1679268221
Browse related groups: Allopathic & Osteopathic Physicians|Family Medicine MS NOVARTIS PHARMACEUTICALS CORPORATION All categories
General Payments — all program years on this page
$115.27
- Category: General Payments
- Program years: PY2024
- Record count: 7
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $115.27 across 7 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $115.27 | 7 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| NOVARTIS PHARMACEUTICALS CORPORATION | $35.16 | 2 |
| Lilly USA, LLC | $32.68 | 2 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $27.26 | 2 |
| Novo Nordisk AS | $20.17 | 1 |
By program year
| Program year | Amount | Records |
|---|---|---|
| 2024 | $115.27 | 7 |
Records — PY2024 (7)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1087297911 | Novartis Pharmaceuticals Corporation | $21.04 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1087297913 | Novartis Pharmaceuticals Corporation | $14.12 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1097468868 | Novo Nordisk Inc | $20.17 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1118105987 | Boehringer Ingelheim Pharmaceuticals, Inc. | $13.61 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1118105989 | Boehringer Ingelheim Pharmaceuticals, Inc. | $13.65 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1136000933 | Lilly USA, LLC | $16.56 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1136002241 | Lilly USA, LLC | $16.12 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.